We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hey gixer, superb stuff. I'm hoping the study is near completion.
Do u know what this study will help us to achieve. Maybe I'm too hung up on the fact SAMR doesn't allow healthy blood flow / platelet function claims! So, not sure what we will achieve.
It has occurred to me that I imagine Aspirin is sold in China for secondary prevention of heart disease , so how are they able to market their health claims given the Bluecap constraints?
...Perhaps Aspirin is evaluated differently as a drug as opposed to a supplement.
Note the study period. And some want news now.
Go figure
Good find but extremely niche reading! It would be far better to have a trading update. SEVEN MONTHS without a word from the BOD. An absolute disgrace!
Effect of combination of Fruitflow and aspirin on platelet function and endothelial cells
Objectives of Study
In vivo and cell tests were conducted to investigate the effects of Fruitflow? and the combination of Fruitflow? and aspirin on platelet function and endothelial cell function in healthy people over 50 years old and in sub-healthy people (at risk of cardiovascular disease).
Date of Registration:2020-07-12
Study execute time:From 2019-02-26 To 2020-11-13
Looks like 400 participants so if my memory is correct, its the biggest so far.
http://www.chictr.org.cn/showprojen.aspx?proj=56370
Sock
I'd imagine it was as simple as SIS didn't sell enough of that particular product to turn a decent profit on it, so they dropped it and concentrated on products they thought were more likely to be big sellers and/or be high margin ?
BB
Sock
in my opinion, breaking all ties with the former CEO needed to happen.......
W$
Thanks, gixer. Maybe it was to encourage sales for FF+. ........ But if it was sold with SIS product(s), it would help to get the word out about Fruitflow. So, I don't get it. It's been something on my mind for a few years.
The fruitflow product was discontinued years ago, no idea why.
Does anybody know why Fruitflow is not in their products?
We are popping up all over the place
We are references #81,82,83
https://iris.uniroma1.it/retrieve/handle/11573/1416315/1493518/Bernardi_Diet_2020.pdf
W$
will try to connect with him on Linkedin :)
yes david, he worked for provexis
Dr Felix Zhang was involved in the invention of Fruitflow, now he is one of the directors of By Health, interesting
https://www.linkedin.com/in/felix-zhang-a7ab8062/?originalSubdomain=cn
Can't believe the silly old buffer. Now he's got it in for our most vital asset, along with Dr Asim. Look out Doc, you're next in the firing line.
What investor tries to remove the brains of an operation? Words fail me. We've just about doubled this year, thanks Mr Lucas, which is excellent progress. Because he sold most of his holding, he needs 12p to break even, and this is everyone's fault but his. Crackers.
Does she tweet/comment or has she joined the wall of silence? Difficult to judge what positive impact she has had since joining the inner sanctum.
wellsite, from your article:-
," blood flow and vascular integrity. Hyperactive platelets interact with vessel walls by shedding macro particles, secreting several adhesive growth factors, and inflammatory agents interrupt the blood flow and produce a pro-thrombotic state in people with obesity, diabetes, a sedentary life style or hypertension, and in people who smoke. It has long been known that disturbances in blood flow, changes in platelet reactivity and enhanced coagulation reactions facilitate pathological thrombus formation, and the maintenance of normal platelet activity is critical to overall hemostasis"
". Fruitflow® developed from tomato and KFE containing bioavailable cardio-protective compounds can be of benefit to the people who are vulnerable to develop CVD. "
gixer
yes the prof is interested in the impact of copper on CV19
https://www.researchgate.net/search/publication?q=duttaroy
W$
wellsite, scary stuff for sure. Hopefully DSM are on the case with FF but to be honest I am not holding my breath.
I follow Asim Duttaroy on Facebook and he posts regularly about COVID-19 but has not once made a connection to FF.
What does that mean..... I don't know.
There won't be one. That would require someone doing something in the best interests of the stakeholders. Some AIM companies realise that constant dilution and a paucity of information eventually ensures that they lose the confidence of the people who fund their lifestyles. IMO, PXS is an example of a company who don't give a tinkers about updates. The CEO/FD lives on the other side of the world, issues no information, is very handsomely remunerated and does not reply to emails unless he thinks you're one of his acolytes. All IMHO, but I challenge anyone to take issue with the four points I made above. Alf, please bear in mind, I don't see your posts anymore so save the vitriol for someone who can see what you write!
gixer
I’m looking for a statement re Covid and FF
This just popped up, blood clots in every organ
https://edition.cnn.com/2020/07/10/health/what-coronavirus-autopsies-reveal/index.html
W$
alfista,
"I get the impression that the working in confidentiality ingrains perhaps a little too much."
Could be but a trading update could easily include the published studies / trials form By-Health and would be breaking no confidentiality as its already in the public domain even if pxs cant go into the finer details of Blue Cap etc.
Don’t require a monthly, quarterly, H1 or2 update, but with all what’s going/gone on some correspondence from the company would be welcome.
Without the wonderful research from Gixer we wouldn’t know of any new products etc that’s been introduced to the market.
So One does agree with colbaltblue post, but only if said by a n other.
It sure would.
I get the impression that the working in confidentiality ingrains perhaps a little too much.
Not easy.
Agree alfista, news will come when its due.
A trading update would still be good though.